Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Plasmodium falciparum | glutathione reductase | Curated by TDR Targets | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Plasmodium falciparum | dihydrolipoyl dehydrogenase, apicoplast | glutathione reductase | 500 aa | 561 aa | 24.4 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium vivax | thioredoxin reductase, putative | 0.0076 | 1 | 1 |
Plasmodium falciparum | thioredoxin reductase | 0.0076 | 1 | 1 |
Loa Loa (eye worm) | glutathione reductase | 0.0076 | 1 | 0.5 |
Trypanosoma brucei | trypanothione reductase | 0.0076 | 1 | 1 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0076 | 1 | 1 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0026 | 0.1234 | 0.5 |
Trichomonas vaginalis | glutathione reductase, putative | 0.0026 | 0.1234 | 0.5 |
Plasmodium vivax | glutathione reductase, putative | 0.0076 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0026 | 0.1234 | 0.5 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0076 | 1 | 1 |
Trichomonas vaginalis | mercuric reductase, putative | 0.0026 | 0.1234 | 0.5 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase | 0.0026 | 0.1234 | 0.5 |
Treponema pallidum | NADH oxidase | 0.0026 | 0.1234 | 0.5 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0076 | 1 | 1 |
Leishmania major | trypanothione reductase | 0.0076 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0026 | 0.1234 | 0.5 |
Chlamydia trachomatis | dihydrolipoyl dehydrogenase | 0.0026 | 0.1234 | 0.5 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0076 | 1 | 0.5 |
Brugia malayi | Thioredoxin reductase | 0.0076 | 1 | 1 |
Plasmodium falciparum | glutathione reductase | 0.0076 | 1 | 1 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase, LpdB | 0.0026 | 0.1234 | 0.5 |
Brugia malayi | dihydrolipoyl dehydrogenase, mitochondrial precursor, putative | 0.0026 | 0.1234 | 0.1234 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0076 | 1 | 1 |
Mycobacterium ulcerans | flavoprotein disulfide reductase | 0.0026 | 0.1234 | 0.5 |
Giardia lamblia | NADH oxidase lateral transfer candidate | 0.0026 | 0.1234 | 0.5 |
Toxoplasma gondii | thioredoxin reductase | 0.0076 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | = 26 % | Anti-inflammatory activity against carrageeenen-induced paw oedema rat model at 10 mg/kg after 3 hrs | ChEMBL. | 17079148 |
Activity (functional) | = 31 % | Analgesic activity in Wistar Albino mouse at 10 mg/kg, po after 3 hrs by tail-flick technique | ChEMBL. | 17079148 |
Activity (functional) | = 31 % | Analgesic activity in Wistar Albino mouse at 10 mg/kg, po after 3 hrs by tail-flick technique | ChEMBL. | 17079148 |
Activity (functional) | = 32 % | Anti-inflammatory activity against carrageeenen-induced paw oedema rat model at 10 mg/kg after 30 mins | ChEMBL. | 17079148 |
Activity (functional) | = 36 % | Anti-inflammatory activity against carrageeenen-induced paw oedema rat model at 10 mg/kg after 1 hr | ChEMBL. | 17079148 |
Activity (functional) | = 36 % | Anti-inflammatory activity against carrageeenen-induced paw oedema rat model at 20 mg/kg after 3 hrs | ChEMBL. | 17079148 |
Activity (functional) | = 37 % | Anti-inflammatory activity against carrageeenen-induced paw oedema rat model at 10 mg/kg after 2 hrs | ChEMBL. | 17079148 |
Activity (functional) | = 38 % | Anti-inflammatory activity against carrageeenen-induced paw oedema rat model at 20 mg/kg after 30 min | ChEMBL. | 17079148 |
Activity (functional) | = 41 % | Analgesic activity in Wistar Albino mouse at 10 mg/kg, po after 30 mins by tail-flick technique | ChEMBL. | 17079148 |
Activity (functional) | = 41 % | Analgesic activity in Wistar Albino mouse at 10 mg/kg, po after 30 mins by tail-flick technique | ChEMBL. | 17079148 |
Activity (functional) | = 42 % | Analgesic activity in Wistar Albino mouse at 20 mg/kg, po after 3 hrs by tail-flick technique | ChEMBL. | 17079148 |
Activity (functional) | = 42 % | Analgesic activity in Wistar Albino mouse at 20 mg/kg, po after 3 hrs by tail-flick technique | ChEMBL. | 17079148 |
Activity (functional) | = 43 % | Analgesic activity in Wistar Albino mouse at 10 mg/kg, po after 1 hr by tail-flick technique | ChEMBL. | 17079148 |
Activity (functional) | = 43 % | Analgesic activity in Wistar Albino mouse at 10 mg/kg, po after 1 hr by tail-flick technique | ChEMBL. | 17079148 |
Activity (functional) | = 45 % | Anti-inflammatory activity against carrageeenen-induced paw oedema rat model at 20 mg/kg after 1 hr | ChEMBL. | 17079148 |
Activity (functional) | = 47 % | Anti-inflammatory activity against carrageeenen-induced paw oedema rat model at 20 mg/kg after 2 hrs | ChEMBL. | 17079148 |
Activity (functional) | = 50 % | Analgesic activity in Wistar Albino mouse at 10 mg/kg, po after 2 hrs by tail-flick technique | ChEMBL. | 17079148 |
Activity (functional) | = 50 % | Analgesic activity in Wistar Albino mouse at 10 mg/kg, po after 2 hrs by tail-flick technique | ChEMBL. | 17079148 |
Activity (functional) | = 55 % | Analgesic activity in Wistar Albino mouse at 20 mg/kg, po after 30 mins by tail-flick technique | ChEMBL. | 17079148 |
Activity (functional) | = 55 % | Analgesic activity in Wistar Albino mouse at 20 mg/kg, po after 30 mins by tail-flick technique | ChEMBL. | 17079148 |
Activity (functional) | = 59 % | Analgesic activity in Wistar Albino mouse at 20 mg/kg, po after 1 hr by tail-flick technique | ChEMBL. | 17079148 |
Activity (functional) | = 59 % | Analgesic activity in Wistar Albino mouse at 20 mg/kg, po after 1 hr by tail-flick technique | ChEMBL. | 17079148 |
Activity (functional) | = 61 % | Analgesic activity in Wistar Albino mouse at 20 mg/kg, po after 2 hrs by tail-flick technique | ChEMBL. | 17079148 |
Activity (functional) | = 61 % | Analgesic activity in Wistar Albino mouse at 20 mg/kg, po after 2 hrs by tail-flick technique | ChEMBL. | 17079148 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.